About us Our Approach Our Pipeline Patients Investors Careers

About us Our Approach Our Pipeline Patients Investors Careers

You are leaving Spyre

If you would like to proceed, click the link to continue.
https://twitter.com/

Spyre is not responsible for content on external websites.
Please review their Privacy Policy.

James Myers

VP, Quality and Compliance

Approach Therapeutic Targets Half-life Extension Rational Combinations Publications

Pipeline Programs

Corporate Presentation Overview News & Events Stock Information Corporate Governance Financial Information IR Resources

Spyre Commitment Clinical trials & Disease Ed

Values Benefits Careers

Terms of Service Privacy Policy

© 2025 Spyre Therapeutics, Inc. All Rights Reserved. For U.S. residents only

Design and development by Visual Science 2024